Patient P-01631

Synthetic patientNBL-101 · Day 112 · 65–74 · F · baseline S14Steering view · 3D Open companion preview

Therapy response

Stable

Tolerance

Improving

GI state

Deteriorating

Inflammatory state

Deteriorating

Nutritional resilience

Declining

Discontinuation risk

63%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 NBL-101 started — Baseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability+26
Inflammatory activity+11
Nutritional resilience-7
Toxicity-5
Treatment adherence+4

What helped?

No interventions yet.

LIFE OS recommendation

Clinician Review CR-01

77%

probability of meaningful tolerance improvement

284 similar trajectories
100% showed improvement
median effect visible after 5 days

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

GI burden

Companion

35.9/100

improving · -4.0 vs previous 14 d

Toxicity

Blood

16.4/100

improving · -6.4 vs previous 14 d

Sleep quality

Wearable

24/100

improving · +3.5 vs previous 14 d

Energy level

Daily log

5.1/10

improving · +0.3 vs previous 14 d

Stress level

Daily log

4.6/10

stable · -0.1 vs previous 14 d

Steps

Wearable

1,223

worsening · -286 vs previous 14 d

Adherence

Companion

93.1 %

improving · +4.0 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards failing · 58 from the failing basin, 29 from restoration.

Would help

ME-01 Monitoring Escalation
100% improved among 12 similar · onset 3 d · confidence 65%

Would not help

HY-01 Hydration Protocol
only 40% improved among 10 similar
Keep alcohol low
GI +4.1 next day on high-intake days · n 17

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Alcohol
+4.1detractor · 95%
Insoluble fibre
-2.3no signal · 51%
Simple carbohydrates
-1.3no signal · 26%
Dietary fat load
-1.1no signal · 18%
Histamine load
-0.5no signal · 15%
Spicy / capsaicin
+0.5no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Autonomic recovery ↓65
- WearableResting HR 75 bpm
- Wearable1,223 steps/day
- WearableShort sleep window
Inflammatory signalling ↑60
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 29 ms, trending down
Mucosal barrier integrity ↓10
- WearableSleep 5.9 h, below personal baseline

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.8 · butyrate capacity 51/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 33 ms
Sleep: 6.9 h
Steps: 3,657
Resting HR: 71 bpm

Daily log: GI score 36, nutritional resilience 59, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Avoid known triggers for now: fried or oily food, dairy, alcohol

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Protect a 7.5-hour sleep window; screens off 30 minutes before
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the scheduled dose as agreed with your care team
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-01804	49%	S19	AD-05	improved	61
P-01541	31%	S09	AD-05	no change	43
P-01377	30%	S11	AD-05	no change	42
P-01483	30%	S14	AD-05	no change	35
P-01679	28%	S12	AD-05	no change	39
P-01689	31%	S13	BR-03	no change	50
P-01350	29%	S19	BR-03	no change	34
P-01313	27%	S01	BR-03	improved	32
P-01329	27%	S08	BR-03	improved	79
P-01430	48%	S05	CR-01	improved	54
P-01371	30%	S06	CR-01	improved	63
P-01442	27%	S13	CR-01	improved	61